A synthetic rhamnose glycopolymer cell surface receptor for endogenous antibody recruitment.
Synthetic materials capable of engineering the immune system are of great relevance in the fight against cancer to replace or complement the current monoclonal antibody and cell therapy based immunotherapeutics. Here we report on antibody recruiting glycopolymers (ARGPs). ARGPs consist of polymeric copies of a rhamnose motif which can bind endoge-nous anti-rhamnose antibodies present in human serum. As a proof-of-concept we have de-signed ARGPs with a lipophilic end-group that efficiently inserts into cell surface mem-branes. We validate the specificity of rhamnose to attract antibodies from human serum to the target cell surface and demonstrate that ARGPs outperform an analogous small molecule compound containing only one single rhamnose motif. The ARGP concept opens new ave-nues for the design of potent immunotherapeutics that mark target cells for destruction by the immune system through antibody-mediated effector functions.